ME01546B - Liksisenatid kao dodatna terapija insulin glarginu i metforminu za liječenje dijabetesa tipa 2 - Google Patents

Liksisenatid kao dodatna terapija insulin glarginu i metforminu za liječenje dijabetesa tipa 2

Info

Publication number
ME01546B
ME01546B MEP-2012-147A MEP14712A ME01546B ME 01546 B ME01546 B ME 01546B ME P14712 A MEP14712 A ME P14712A ME 01546 B ME01546 B ME 01546B
Authority
ME
Montenegro
Prior art keywords
lixisenatide
metformin
diabetes
therapy
add
Prior art date
Application number
MEP-2012-147A
Other languages
English (en)
Inventor
Louise Silvestre
Elisabeth Souhami
Xiaodan Wei
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41800749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01546(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of ME01546B publication Critical patent/ME01546B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
MEP-2012-147A 2009-11-13 2009-11-13 Liksisenatid kao dodatna terapija insulin glarginu i metforminu za liječenje dijabetesa tipa 2 ME01546B (me)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09175877.1A EP2329848B2 (en) 2009-11-13 2009-11-13 Lixisenatide as add-on therapy to insulin glargine and metformin for treating type 2 diabetes

Publications (1)

Publication Number Publication Date
ME01546B true ME01546B (me) 2014-04-20

Family

ID=41800749

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2012-147A ME01546B (me) 2009-11-13 2009-11-13 Liksisenatid kao dodatna terapija insulin glarginu i metforminu za liječenje dijabetesa tipa 2

Country Status (11)

Country Link
EP (1) EP2329848B2 (me)
CY (1) CY1113755T1 (me)
DK (1) DK2329848T4 (me)
ES (1) ES2398012T5 (me)
HR (1) HRP20121029T4 (me)
ME (1) ME01546B (me)
PL (1) PL2329848T5 (me)
PT (1) PT2329848E (me)
RS (1) RS52629B2 (me)
SI (1) SI2329848T2 (me)
SM (1) SMT201300013B (me)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122013025625B1 (pt) 2008-10-17 2021-08-03 Sanofi-Aventis Deutschland Gmbh Composição farmacêutica, seu uso e método de preparação da mesma, kit e dispositivo
DK2498802T3 (en) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine
MY159565A (en) 2009-11-13 2017-01-13 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
HUE031181T2 (en) 2010-08-30 2017-06-28 Sanofi Aventis Deutschland Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
AU2012213435B2 (en) * 2011-02-02 2017-03-30 Sanofi-Aventis Deutschland Gmbh Prevention of hypoglycaemia in diabetes mellitus type 2 patients
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
KR101983982B1 (ko) 2011-08-29 2019-05-30 사노피-아벤티스 도이칠란트 게엠베하 2형 당뇨병 환자의 혈당 조절에 사용하기 위한 약제학적 병용물
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
MX359329B (es) * 2011-10-28 2018-09-25 Sanofi Aventis Deutschland Una combinación farmacéutica para usarse en el tratamiento de un paciente que padece diabetes tipo 2.
EP3517122A1 (en) 2013-04-03 2019-07-31 Sanofi Treatment of diabetes mellitus by long-acting formulations of insulins
US20140371141A1 (en) * 2013-06-17 2014-12-18 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels

Also Published As

Publication number Publication date
HRP20121029T4 (hr) 2019-10-18
DK2329848T3 (da) 2013-02-04
SI2329848T2 (sl) 2019-10-30
RS52629B (en) 2013-06-28
EP2329848B1 (en) 2012-10-24
CY1113755T1 (el) 2016-07-27
EP2329848B2 (en) 2019-06-19
PT2329848E (pt) 2013-01-23
SI2329848T1 (sl) 2013-02-28
RS52629B2 (sr) 2019-11-29
EP2329848A1 (en) 2011-06-08
PL2329848T3 (pl) 2013-05-31
SMT201300013B (it) 2013-03-08
PL2329848T5 (pl) 2019-12-31
DK2329848T4 (da) 2019-09-09
HRP20121029T1 (hr) 2013-01-31
ES2398012T5 (es) 2020-02-26
ES2398012T3 (es) 2013-03-13

Similar Documents

Publication Publication Date Title
HRP20121029T1 (hr) Liksisenatid kao pomoä†na terapija uz inzulin glargin i metformin kod lijeäśenja dijabetesa tip 2
HRP20170209T1 (hr) Liksisenatid kao dodatna terapija uz bazalni inzulin kod dijabetesa tipa 2
PL2324853T3 (pl) Liksysenatyd jako dodatek do metforminy w leczeniu cukrzycy typu 2
IL219945A (en) 1-GLP history with dual transduction and use of it to prepare a drug for the treatment of diabetes
IL250548B (en) Acetyl analogs of insulin that are resistant to protease and their use for the preparation of a drug for the treatment and prevention of diabetes
IL209887A0 (en) Treatment for diabetes in patients inappropriate for metformin therapy
IL212903A0 (en) Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor
HK1164112A1 (en) Treating hyperglycemia with glp-1 glp-1
PT2707017E (pt) Lixisenatida e metformina para tratamento da diabetes tipo 2
PT2611458T (pt) Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
PT2459207E (pt) Composição farmacêutica para tratamento de condições médicas e um método para tratamento de distúrbios alimentares e doenças relacionadas
ZA201105094B (en) Combination of insulin with triazine derivatives and its use for treating diabetes
GB0919603D0 (en) Use of thymosin beta-4 for treatment of type II diabetes
ZA201008998B (en) Treatment for diabetes in patients inappropriate for metformin therapy
EG27140A (en) Preparation and characterization of metformin as insulin resistant reducing agents for type ii diabetes
ZA200909123B (en) Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
GB0904271D0 (en) Treatment of diabetes and metabolic syndrome
GB0910904D0 (en) Treatment of diabetes and metabolic syndrome
GB0912906D0 (en) Treatment of diabetes and metabolic syndrome